Avanza Fonder AB Decreases Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• Avanza Fonder AB reduced its stake in UnitedHealth Group by 8.8% in Q2, now holding 61,895 shares valued at approximately $19.31 million.
• Institutional investors own 87.86% of UnitedHealth Group, indicating strong confidence and investment in the company.
• UnitedHealth Group declared a quarterly dividend of $2.21 per share, representing a yield of 2.6%, with an ex-dividend date of September 15th.

Avanza Fonder AB reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 8.8% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 61,895 shares of the healthcare conglomerate's stock after selling 5,984 shares during the quarter. UnitedHealth Group makes up about 0.6% of Avanza Fonder AB's portfolio, making the stock its 25th largest holding. Avanza Fonder AB's holdings in UnitedHealth Group were worth $19,309,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Bayforest Capital Ltd grew its position in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after buying an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd lifted its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management acquired a new stake in UnitedHealth Group during the 4th quarter valued at approximately $42,000. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $42,000. Finally, O Brien Wealth Partners LLC raised its stake in UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock worth $46,000 after buying an additional 37 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have weighed in on the company. Piper Sandler decreased their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Baird R W lowered shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research note on Thursday, July 31st. Finally, Barclays raised their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a report on Thursday, September 4th. Sixteen analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Stock Up 1.9%

NYSE:UNH traded up $6.49 on Tuesday, hitting $347.79. The stock had a trading volume of 9,773,475 shares, compared to its average volume of 12,991,036. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The firm's fifty day simple moving average is $296.49 and its two-hundred day simple moving average is $362.50. The stock has a market cap of $314.99 billion, a P/E ratio of 15.06, a price-to-earnings-growth ratio of 2.20 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. During the same period in the previous year, the business posted $6.80 earnings per share. The business's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.